Encapsulation of the Dinuclear Trithiolato-Bridged Arene Ruthenium Complex Diruthenium-1 in an Apoferritin Nanocage: Structure and Cytotoxicity.
Animals
Antineoplastic Agents
/ chemistry
Apoferritins
/ chemistry
Apoptosis
/ drug effects
Cell Line, Tumor
Cell Survival
/ drug effects
Coordination Complexes
/ chemistry
Crystallography, X-Ray
Humans
Mice
Mitochondrial Membranes
/ metabolism
Molecular Conformation
Nanocapsules
/ chemistry
Reactive Oxygen Species
/ metabolism
Sulfhydryl Compounds
/ chemistry
anticancer
diruthenium
drug delivery
ferritin
protein cages
Journal
ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013
Informations de publication
Date de publication:
05 03 2019
05 03 2019
Historique:
received:
18
12
2018
revised:
21
01
2019
pubmed:
24
1
2019
medline:
17
1
2020
entrez:
24
1
2019
Statut:
ppublish
Résumé
The effects of encapsulating the cytotoxic dinuclear trithiolato-bridged arene ruthenium complex [(η
Identifiants
pubmed: 30674089
doi: 10.1002/cmdc.201800805
doi:
Substances chimiques
Antineoplastic Agents
0
Coordination Complexes
0
Nanocapsules
0
Reactive Oxygen Species
0
Sulfhydryl Compounds
0
diruthenium-1
0
Apoferritins
9013-31-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
594-602Informations de copyright
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.